Accredited Continuing Education
The deadline for claiming CME for this event was October 31, 2025.
Please contact [email protected] if you require assistance.
The Society for Cardiovascular Angiography & Interventions is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement
The Society for Cardiovascular Angiography and Interventions designates this live activity for a maximum of 8.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Additionally, learners may earn up to 3.5 AMA PRA Category 1 CreditsTM by participating in the satellite activities.
ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.25 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Additionally, learners may earn up to 3.5 ABIM MOC points by participating in the satellite activities.
Nurses and Radiology Technologists
This educational activity is approved by the Cardiovascular & Pulmonary Continuing Education (CaPCE) for up to 8.25 contact hours of accredited education. Provider approved by the California Board of Registered Nursing, Provider Number CEP15311.
Successful Completion
Pick up your conference badge to create an attendance record. Attend the conference and complete the post-activity evaluation to obtain credit.
Commercial Support
SCAI SHOCK is supported by an unrestricted educational grant from Abiomed. No in-kind support has been received.
Disclosures
Individuals in control of content reported the following relevant financial relationships with ineligible companies during the content development process for this activity. All relevant financial relationships will be mitigated before the start of the activity. A complete list of disclosures for faculty is available in the conference app.
Planners
Allison Dupont, Ruth Fisher, Debbie Rinde-Hoffman, Robert Roswell, and Behnam Tehrani: No relevant financial relationships with ineligible companies.
Jason Grady: Speaker with Abiomed.
Amy Hackman: Consulting and speaker with Abbott. Advisory Board and speaker with Medtronic.
Vika Kagan: Consulting with Abiomed and Abbott.
Jason Katz: Research grant from Abbott.
Sandeep Nathan: Consulting with Abiomed, Terumo, ZOLL, and Getinge.
Planning Reviewer
Allison Dupont: No financial relationships with ineligible companies.
Staff
Rachel Pham: No financial relationships with ineligible companies.
SCAI’s Independent Content
As a provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME), it is the Society’s policy to ensure balance, independence, objectivity, and scientific rigor in all its activities.
Planning Process
SCAI activities are developed by the SCAI planners prior to and independent of commercial support. Members of the SCAI SHOCK Planning Committee reviewed and approved this activity. If planners had relevant financial relationships, the agenda was peer reviewed by a member with no relevant financial relationships.
Mitigation of Relevant Financial Relationships
All participating planners, reviewers, faculty, and staff are required to disclose to SCAI all financial relationships with ineligible companies. SCAI identifies relevant financial relationships and mitigates them before the activity begins.
Content Validation Statement
SCAI accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements for clinical care recommendations.
All clinical and pharmacological recommendations are based on evidence accepted within the medical profession as adequate jurisdiction for their indications and contradictions in patient care. SCAI does not promote recommendations, treatment, or manners of practicing medicine that are not within the definition of accredited continuing education or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients.
All research referenced to support or justify patient care recommendations conforms to accepted standards of experimental design, data collection, and analysis.
SCAI actively promotes improvements in health care and NOT proprietary interests of an ineligible company. SCAI's educational content is free of marketing or sales of products or services.
Faculty will not actively promote or sell products or services that serve their professional or financial interests during accredited education.
SCAI encourages faculty to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration (FDA), at first mention, and where appropriate in the content.